The Lancet Psychiatry Commission on psychological treatments #SeeingFurther

Walking Sideways AFCXWbCGo (1)

Ioana Cristea highlights some of the key ideas from the recently published Lancet Psychiatry Commission on psychological treatments research in tomorrow’s science. She also raises a number of objections to the 50-page report, which we hope will generate some much needed discussion on this topic.

Look out for our #SeeingFurther podcast with the authors of the Commission and a Twitter chat at 12:30pm GMT on Monday 19th March.

[read the full story...]

WHO cares? Treatment coverage for substance use disorders: results from 26 countries


Ian Hamilton reports on an analysis of data from the World Mental Health Surveys, which estimates treatment coverage for people with substance use disorders.

[read the full story...]

Over 1 in 10 women have depression during pregnancy or postnatally #HopeNov20


Emma Molyneaux writes her debut blog about a recent systematic review and meta-regression of the prevalence and incidence of perinatal depression.

We are covering the #HopeNov20 event today at parliament to raise awareness of mental health conditions during pregnancy and beyond. Search Twitter for #HopeNov20 from 1-6pm to follow the conversation.

[read the full story...]

Training alone doesn’t improve outcomes for depression in primary care


Linda Gask writes her debut Mental Elf blog on a recent systematic review, which evaluates healthcare team training programs that aim to improve depression in primary care.

[read the full story...]

Tackling mental-health-related stigma: a narrative review of anti-stigma interventions


Suzanne Dash considers the findings of a recent narrative review in The Lancet, which brought together the evidence for effective interventions to reduce mental-health-related stigma and discrimination.

[read the full story...]

WHO guidelines for mental, neurological and substance use disorders in low- and middle-income countries


The World Health Organization’s Mental Health Gap Action Programme (mhGAP) aims to tackle mental, neurological and substance use disorders in low- and middle-income countries. 14% of the global burden of disease is made up by these disorders and many people do not have access to the treatments they need. The programme asserts that with proper [read the full story…]

Psychotherapies are effective treatments for depression and anxiety in low and middle income countries

African family - Anna Omelchenko Shutterstock

A new meta-analysis published in the African Journal of Psychiatry investigates the efficacy of psychological treatments for depression and anxiety disorders in low and middle income countries. To date there has perhaps existed a view that psychological mindedness is missing amongst the population of developing countries. There is good evidence that psychological treatments work as [read the full story…]